is it calimmune sending blt ballistic, page-5

We can't rule Calimmune out for the price rocket, despite the other possibilites of RNAi rise in general, TT-034, and KSS influence.

Given the trial's readout timing for first patient, and then BLT stock price movement, the first sign of the new pricing came in during Oct.

http://www.bloomberg.com/quote/BLT:AU

And going further, we can't rule out that if it is Calimmune trial news leaking, then we should be due for another burst from the validation of having FDA green light for TT-034 trial start. Or is that too much excitement for 1 stock to handle?